Literature DB >> 21199006

Foe turned friend: multiple functional roles attributable to hyper-activating stem cell factor receptor mutant in regeneration of the haematopoietic cell compartment.

S Pati1, O P Kalra, A Mukhopadhyay.   

Abstract

OBJECTIVES: Stem cell factor receptor, c-kit, is considered to be the master signalling molecule of haematopoietic stem cells. It develops the orchestral pattern of haematopoietic cell lineages, seen by its varying degree of omnipresence in progenitors, lineage committed and mature cells. We have investigated the effect of over-expressing c-kit on early recovery of the haematopoietic compartment, in irradiated hosts.
MATERIALS AND METHODS: Normal bone marrow cells (BMCs) were transfected with Kit(wt) (wild-type c-kit) or its variant Kit(mu) (asp814tyr) by electroporation. Lethally irradiated mice were transplanted with normal or transfected congeneic BMCs. The effect of ectopic expression of c-kit on haematopoietic cell recovery was determined by analysing donor-derived cells. Furthermore, effects of both types of c-kit over-expression on progenitor and lineage-committed cells were examined by flow cytometric analysis of Sca-1 and lineage-committed (Lin(+)) cells respectively.
RESULTS: Hyper-activating Kit(mu) significantly improved recovery of the haematopoietic system in irradiated hosts. In vivo results showed that the donor-derived c-kit(+) cell population was increased to more than 3-fold in the case of Kit(mu)-transfected cells compared to normal and Kit(wt) over-expressing BMCs. In general, survival of progenitor and committed cell was improved in the Kit(mu) over-expressing system compared to the other two cohorts.
CONCLUSION: These results suggest that recruitment of the hyper-activating variant of c-kit (Kit(mu)) lead to early recovery of the bone marrow of lethally irradiated mice.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21199006      PMCID: PMC6496452          DOI: 10.1111/j.1365-2184.2010.00713.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  33 in total

Review 1.  In vitro and in vivo expansion of hematopoietic stem cells.

Authors:  Guy Sauvageau; Norman N Iscove; R Keith Humphries
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

Review 2.  Proliferative senescence in hematopoietic stem cells during ex-vivo expansion.

Authors:  Wanda Piacibello; Loretta Gammaitoni; Ymera Pignochino
Journal:  Folia Histochem Cytobiol       Date:  2005       Impact factor: 1.698

Review 3.  The beauty of asymmetry: asymmetric divisions and self-renewal in the haematopoietic system.

Authors:  Anthony D Ho; Wolfgang Wagner
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

4.  Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.

Authors:  X Piao; R Paulson; P van der Geer; T Pawson; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  c-Kit expression and stem cell factor-induced hematopoietic cell proliferation are up-regulated in aged B6D2F1 mice.

Authors:  Aleah L Smith; Felicia M Ellison; J Philip McCoy; Jichun Chen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-04       Impact factor: 6.053

Review 6.  Occurrence of leukaemia following gene therapy of X-linked SCID.

Authors:  Donald B Kohn; Michel Sadelain; Joseph C Glorioso
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

7.  Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation.

Authors:  Z Wang; P J Troilo; X Wang; T G Griffiths; S J Pacchione; A B Barnum; L B Harper; C J Pauley; Z Niu; L Denisova; T T Follmer; G Rizzuto; G Ciliberto; E Fattori; N L Monica; S Manam; B J Ledwith
Journal:  Gene Ther       Date:  2004-04       Impact factor: 5.250

8.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines.

Authors:  Ewa Wandzioch; Charlotte E Edling; Ruth H Palmer; Leif Carlsson; Bengt Hallberg
Journal:  Blood       Date:  2004-03-02       Impact factor: 22.113

10.  Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.

Authors:  R Shivakrupa; Alan Bernstein; Nicole Watring; Diana Linnekin
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  1 in total

1.  Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Authors:  Yuanhao Zhang; Xiuwei Pan; Zhen Shi; Haibo Cai; Yun Gao; Weian Zhang
Journal:  Cell Prolif       Date:  2017-11-15       Impact factor: 6.831

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.